CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) In Millions, except Share data, unless otherwise specified	3 Months Ended
	Apr. 02, 2011	Apr. 03, 2010
Revenues	$ 1,199.0	$ 1,084.6
Costs and expenses:
Cost of products sold	849.7	771.4
Selling, general and administrative	287.6	248.3
Intangible amortization	7.2	6.2
Special charges, net	3.1	6.8
Operating income	51.4	51.9
Other income (expense), net	2.7	(12.1)
Interest expense	(24.0)	(20.5)
Interest income	1.3	1.6
Equity earnings in joint ventures	8.8	8.7
Income from continuing operations before income taxes	40.2	29.6
Income tax provision	(13.5)	(11.7)
Income from continuing operations	26.7	17.9
Loss from discontinued operations, net of tax		(0.2)
Gain (loss) on disposition of discontinued operations, net of tax	(1.9)	3.6
Income (loss) from discontinued operations, net of tax	(1.9)	3.4
Net income	24.8	21.3
Less: Net income (loss) attributable to noncontrolling interests	1.7	(0.8)
Net income attributable to SPX Corporation common shareholders	23.1	22.1
Amounts attributable to SPX Corporation common shareholders:
Income from continuing operations, net of tax	25.0	18.7
Income (loss) from discontinued operations, net of tax	(1.9)	3.4
Net income	$ 23.1	$ 22.1
Basic income per share of common stock:
Income from continuing operations attributable to SPX Corporation common shareholders (in dollars per share)	$ 0.50	$ 0.38
Income (loss) from discontinued operations attributable to SPX Corporation common shareholders (in dollars per share)	$ (0.04)	$ 0.07
Net income per share attributable to SPX Corporation common shareholders (in dollars per share)	$ 0.46	$ 0.45
Weighted-average number of common shares outstanding - basic (in shares)	50.264	49.530
Diluted income per share of common stock:
Income from continuing operations attributable to SPX Corporation common shareholders (in dollars per share)	$ 0.49	$ 0.37
Income (loss) from discontinued operations attributable to SPX Corporation common shareholders (in dollars per share)	$ (0.04)	$ 0.07
Net income per share attributable to SPX Corporation common shareholders (in dollars per share)	$ 0.45	$ 0.44
Weighted-average number of common shares outstanding - diluted (in shares)	50.940	49.921

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $) In Millions, unless otherwise specified	3 Months Ended	12 Months Ended
	Apr. 02, 2011	Dec. 31, 2010
Current assets:
Cash and equivalents	$ 372.0	$ 455.4
Accounts receivable, net	1,198.4	1,164.8
Inventories	614.9	564.3
Other current assets	181.1	176.1
Deferred income taxes	72.6	67.9
Total current assets	2,439.0	2,428.5
Property, plant and equipment:
Land	39.9	40.8
Buildings and leasehold improvements	271.2	264.1
Machinery and equipment	788.3	767.1
Property, plant and equipment, gross	1,099.4	1,072.0
Accumulated depreciation	(546.8)	(526.8)
Property, plant and equipment, net	552.6	545.2
Goodwill	1,690.3	1,634.6
Intangibles, net	748.4	719.5
Other assets	673.2	665.5
TOTAL ASSETS	6,103.5	5,993.3
Current liabilities:
Accounts payable	560.9	538.8
Accrued expenses	1,015.2	1,080.1
Income taxes payable	16.3	16.3
Short-term debt	88.2	36.3
Current maturities of long-term debt	22.7	50.8
Total current liabilities	1,703.3	1,722.3
Long-term debt	1,111.0	1,110.5
Deferred and other income taxes	89.5	86.9
Other long-term liabilities	976.8	969.6
Total long-term liabilities	2,177.3	2,167.0
Commitments and contingent liabilities (Note 13)
SPX Corporation shareholders' equity:
Common stock (98,614,016 and 50,985,674 issued and outstanding at April 2, 2011, respectively, and 98,068,416 and 50,294,261 issued and outstanding at December 31, 2010, respectively)	991.0	986.7
Paid-in capital	1,471.4	1,461.1
Retained earnings	2,369.0	2,358.6
Accumulated other comprehensive loss	(103.5)	(192.6)
Common stock in treasury (47,628,342 and 47,774,155 shares at April 2, 2011 and December 31, 2010, respectively)	(2,510.4)	(2,516.1)
Total SPX Corporation shareholders' equity	2,217.5	2,097.7
Noncontrolling interests	5.4	6.3
Total equity	2,222.9	2,104.0
TOTAL LIABILITIES AND EQUITY	$ 6,103.5	$ 5,993.3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Millions, unless otherwise specified	3 Months Ended
	Apr. 02, 2011	Apr. 03, 2010
Cash flows used in operating activities:
Net income	$ 24.8	$ 21.3
Less: Income (loss) from discontinued operations, net of tax	(1.9)	3.4
Income from continuing operations	26.7	17.9
Adjustments to reconcile income from continuing operations to net cash used in operating activities:
Special charges, net	3.1	6.8
Deferred and other income taxes	4.0	9.3
Depreciation and amortization	28.5	27.8
Pension and other employee benefits	15.0	17.4
Stock-based compensation	19.7	11.9
Other, net	(0.6)	10.9
Changes in operating assets and liabilities, net of effects from acquisitions and divestitures:
Accounts receivable and other assets	(26.3)	(49.3)
Inventories	(27.9)	(1.9)
Accounts payable, accrued expenses, and other	(68.1)	(65.3)
Cash spending on restructuring actions	(9.5)	(10.7)
Net cash used in continuing operations	(35.4)	(25.2)
Net cash used in discontinued operations	(0.8)	(1.5)
Net cash used in operating activities	(36.2)	(26.7)
Cash flows used in investing activities:
Proceeds from assets sales and other		0.3
Increase in restricted cash	(1.8)	(5.8)
Business acquisitions, net of cash acquired	(46.5)	(26.8)
Capital expenditures	(16.4)	(11.8)
Net cash used in continuing operations	(64.7)	(44.1)
Net cash from discontinued operations (includes net cash proceeds from dispositions of $6.7 for the three months ended April 3, 2010)		6.7
Net cash used in investing activities	(64.7)	(37.4)
Cash flows from financing activities:
Borrowings under senior credit facilities	95.0	102.0
Repayments under senior credit facilities	(95.0)	(78.3)
Repayments under senior notes	(28.2)
Borrowings under trade receivables agreement	72.0	10.0
Repayments under trade receivables agreement	(21.0)	(3.0)
Net borrowings (repayments) under other financing arrangements	0.6	(0.1)
Minimum withholdings paid on behalf of employees for net share settlements, net of proceeds from the exercise of employee stock options and other	(3.5)	(8.0)
Financing fees paid		(1.0)
Dividends paid (includes noncontrolling interest distributions for the three months ended April 2, 2011 of $2.9)	(15.5)	(12.4)
Net cash from continuing operations	4.4	9.2
Net cash from discontinued operations	0	0
Net cash from financing activities	4.4	9.2
Change in cash and equivalents due to changes in foreign currency exchange rates	13.1	(3.9)
Net change in cash and equivalents	(83.4)	(58.8)
Consolidated cash and equivalents, beginning of period	455.4	522.9
Consolidated cash and equivalents, end of period	$ 372.0	$ 464.1

NEW ACCOUNTING PRONOUNCEMENTS

3 Months Ended

Apr. 02, 2011

NEW ACCOUNTING PRONOUNCEMENTS

NEW ACCOUNTING PRONOUNCEMENTS

(2) NEW ACCOUNTING PRONOUNCEMENTS

The following is a summary of new accounting pronouncements that apply or may apply to our business.

In September 2009, the Financial Accounting Standards Board (“FASB”) issued guidance with the objective of amending revenue recognition for arrangements with multiple deliverables. The guidance eliminates one previous revenue recognition criterion so that objective and reliable evidence of fair value for undelivered item(s), in a multiple element deliverable arrangement in which the delivered item or items are considered a separate unit or units, is no longer required. The guidance also determines a hierarchy for an entity to use when estimating the selling price of deliverables that meet the other two conditions for separation as follows: (1) vendor-specific objective evidence of the selling price, (2) third-party evidence of the selling price, or (3) an estimate of the selling price. In addition, the term “selling price” replaces all references to fair value in the guidance. The guidance also has eliminated the residual allocation method and requires an entity to apply the relative selling price allocation method in all circumstances where there is an absence of objective and reliable evidence for the delivered item(s) in an arrangement. Lastly, the guidance requires enhanced disclosures about the judgments and assumptions used in evaluating arrangements. Entities may elect to apply this guidance (1) prospectively to new or materially modified arrangements after the effective date or (2) retrospectively for all periods presented. The guidance is effective for fiscal years beginning on or after June 15, 2010. We adopted this guidance on January 1, 2011 with no material impact on our consolidated financial statements.

In September 2009, the FASB issued an amendment to guidance related to revenue recognition for certain revenue arrangements that include software elements. The amendment was to the scope of prior guidance, such that all tangible products containing both software and non-software components that function together to deliver the product’s essential functionality will no longer be within the scope of the Software Revenue Recognition Topic of the Accounting Standards Codification (“Codification”). That is, the entire product (including the software deliverables and non-software deliverables) would be outside the scope of revenue recognition guidance specific to software and would be accounted for under other accounting literature. Lastly, the guidance requires enhanced disclosures about the judgments and assumptions used in evaluating arrangements. Entities may elect to apply this guidance (1) prospectively to new or materially modified arrangements after the effective date or (2) retrospectively for all periods presented. The guidance is effective for fiscal years beginning on or after June 15, 2010. We adopted this guidance on January 1, 2011 with no material impact on our consolidated financial statements.

In December 2010, the FASB issued guidance to modify the goodwill impairment test by eliminating an entity’s ability to assert that a reporting unit is not required to perform Step 2 of the goodwill impairment test if the carrying amount of the reporting unit is zero or negative, despite the existence of qualitative factors that indicate that the goodwill is more likely than not impaired. For such reporting units, an entity is required to perform Step 2 of the goodwill impairment test if it is more likely than not that goodwill impairment exists. In determining whether it is more likely than not that a goodwill impairment exists, an entity should consider whether there are any adverse qualitative factors indicating that impairment may exist. The qualitative factors are consistent with the existing guidance, which require that goodwill of a reporting unit be tested for impairment between interim or annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount. The guidance is effective for the first reporting period beginning after December 15, 2010. We adopted the guidance on January 1, 2011 with no material impact on our consolidated financial statements.

In December 2010, the FASB issued guidance to clarify that if a public entity presents comparative financial statements for business combinations that are material on an individual or aggregate basis, the entity should disclose revenues and earnings of the combined entity as though the business combination had occurred as of the beginning of the comparable prior annual reporting period only. Additionally, the guidance expands the supplemental pro forma disclosures to include a description of the nature and amount of material, nonrecurring, adjustments directly attributable to the business combination included in the reported pro forma revenue and earnings. The guidance is effective prospectively for business combinations for which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after December 15, 2010. We adopted the guidance on January 1, 2011 with no material impact on our consolidated financial statements; however, the guidance will have an impact on our consolidated financial statements for material acquisitions consummated after January 1, 2011.

ACQUISITIONS AND DISCONTINUED OPERATIONS

3 Months Ended

Apr. 02, 2011

ACQUISITIONS AND DISCONTINUED OPERATIONS

ACQUISITIONS AND DISCONTINUED OPERATIONS

(3) ACQUISITIONS AND DISCONTINUED OPERATIONS

Acquisitions

In March 2011, in the Test and Measurement segment, we completed the acquisition of substantially all of the assets of Teradyne Inc.’s Diagnostic Solutions business (“DS”), a leading global supplier of diagnostic solutions for transportation OEMs and automotive dealerships, for a purchase price of $39.1. DS had revenues of approximately $42.0 in the twelve months prior to the date of acquisition.

In March 2011, in the Flow Technology segment, we completed the acquisition of B.W. Murdoch Ltd (“Murdoch”), a leading engineering company supplying processing solutions for the food and beverage industry, for a purchase price of $7.4. Murdoch had revenues of approximately $13.0 in the twelve months prior to the date of acquisition.

In July 2010, in the Flow Technology segment, we completed the acquisition of the Anhydro business (“Anhydro”), a global supplier of liquid concentration equipment, powder processing solutions, and dewatering plants and equipment, for a purchase price of $59.1, net of cash acquired of $10.9. Anhydro had revenues of approximately $71.0 in the twelve months prior to the date of acquisition.

In April 2010, in the Industrial Products and Services segment, we completed the acquisition of Torque Tension Systems Ltd. (“TTS”), a leading global supplier of hydraulic torque wrench and tensioner tool products, for a purchase price of $15.7, net of cash acquired of $2.4. TTS had revenues of approximately $9.0 in the twelve months prior to the date of acquisition.

In February 2010, in the Flow Technology segment, we completed the acquisition of Gerstenberg Schröder A/S (“Gerstenberg”), a leading designer, manufacturer, installer and servicer of processing systems and components serving the global food industry, for a purchase price of $30.9, net of cash acquired of $3.5 and including debt assumed of $3.9. Gerstenberg had revenues of approximately $57.0 in the twelve months prior to the date of acquisition.

The pro forma effects of these acquisitions were not material, individually or in the aggregate, to our results of operations.

The assets acquired and liabilities assumed were recorded at preliminary estimates of fair values as determined by management, based on information available at the acquisition date and on current assumptions as to future operations, and are subject to change during the measurement period upon the completion of acquisition accounting, including the finalization of asset valuations and any working capital settlements.

Discontinued Operations

As part of our operating strategy, we regularly review and negotiate potential divestitures, some of which are or may be material. As a result of this continuous review, we determined that certain of our businesses would be better strategic fits with other companies or investors.

We report businesses or asset groups as discontinued operations when, among other things, we commit to a plan to divest the business or asset group, actively begin marketing the business or asset group, and when the sale of the business or asset group is deemed probable within the next twelve months. The following businesses, which have been sold, met these requirements and therefore have been reported as discontinued operations for the periods presented.

Business	Quarter Discontinued	Quarter of Sale
Cooling Spain Packaging business (“Cooling Spain”)	Q4 2010	Q4 2010
P.S.D., Inc. (“PSD”)	Q2 2009	Q1 2010

Cooling Spain — Sold for cash consideration of one Euro (exclusive of cash transferred with the business of $2.3), resulting in a loss, net of taxes, of $1.9 during the fourth quarter of 2010. During the first quarter of 2011, we recorded a net charge of $0.1 to “Gain (loss) on disposition of discontinued operations, net of taxes” within our condensed consolidated statements of operations in connection with adjustments to certain liabilities that we retained.

PSD — Sold for cash consideration of $3.0, resulting in a gain, net of taxes, of $3.6 during the first quarter of 2010.

In addition to the businesses discussed above, we recognized a net loss of $1.8 during the first quarter of 2011 resulting from adjustments to gains/(losses) on sales from previously discontinued businesses. Refer to the consolidated financial statements contained in our 2010 Annual Report on Form 10-K for the disclosure of all discontinued businesses during 2008 through 2010.

The final sales price for certain of the divested businesses is subject to adjustment based on working capital existing at the respective closing dates. The working capital figures are subject to agreement with the buyers or, if we cannot come to agreement, an arbitration process. Final agreement of the working capital figures for certain of these transactions has yet to occur. In addition, changes in estimates associated with liabilities retained in connection with a business divestiture (e.g., income taxes) may occur. It is possible that the sales price and resulting gains/losses on these, and other previous divestitures, may be materially adjusted in subsequent periods.

For the first three months of 2011 and 2010, income (loss) from discontinued operations and the related income taxes are shown below:

	Three months ended
	April 2,			April 3,
	2011			2010
Income (loss) from discontinued operations	$	(2.1	)	$	2.0
Income tax benefit	0.2			1.4
Income (loss) from discontinued operations, net	$	(1.9	)	$	3.4

For the first three months of 2011 and 2010, results of operations for our businesses reported as discontinued operations were as follows:

	Three months ended
	April 2,		April 3,
	2011		2010
Revenues	$	—	$	2.9
Pre-tax loss	—		(0.2		)

There were no assets or liabilities attributable to discontinued operations at April 2, 2011 and December 31, 2010.

BUSINESS SEGMENT INFORMATION

3 Months Ended

Apr. 02, 2011

BUSINESS SEGMENT INFORMATION

BUSINESS SEGMENT INFORMATION

(4) BUSINESS SEGMENT INFORMATION

We are a global provider of flow technology, test and measurement products and services, thermal equipment and services and industrial products and services with operations in over 35 countries. We offer a diverse collection of products, which include, but are not limited to, valves, fluid handling equipment, metering and mixing solutions, specialty service tools, diagnostic systems, service equipment and technical information services, cooling, heating and ventilation products, power transformers, and TV and radio broadcast antennas. Our products are used by a broad array of customers in various industries, including power generation, chemical processing, pharmaceuticals, infrastructure, mineral processing, petrochemical, automotive service, telecommunications and transportation.

We aggregate our operating segments into four reportable segments: Flow Technology, Test and Measurement, Thermal Equipment and Services and Industrial Products and Services. The factors considered in determining our aggregated segments are the economic similarity of the businesses, the nature of products sold or services provided, production processes, types of customers and distribution methods. In determining our segments, we apply the threshold criteria of the Segment Reporting Topic of the Codification to operating income or loss of each segment before considering impairment and special charges, pensions and postretirement expense, stock-based compensation and other indirect corporate expenses. This is consistent with the way our chief operating decision maker evaluates the results of each segment.

Flow Technology

Our Flow Technology segment designs, manufactures and markets products and solutions that are used to process, blend, filter, dry, meter and transport fluids with a focus on creating innovative new products and systems, as well as providing comprehensive aftermarket support services. Primary offerings include engineered pumps, mixers, process systems, heat exchangers, valves, and dehydration and drying technologies. The segment continues to focus on optimizing its global footprint while taking advantage of cross-product integration opportunities and increasing its competitive position in global end markets. Flow Technology’s solutions focus on key business drivers, such as product flexibility, process optimization, sustainability and safety.

Test and Measurement

Our Test and Measurement segment engineers and manufactures branded, technologically advanced test and measurement products used on a global basis across the transportation, telecommunications and utility industries. Our technology supports the introduction of new systems, expanded services and sophisticated testing and validation. Products of the segment include specialty automotive diagnostic service tools, fare-collection systems and portable cable and pipe locators. The segment continues to focus on global expansion, with a specific focus on China and India.

Thermal Equipment and Services

Our Thermal Equipment and Services segment engineers, manufactures and services cooling, heating and ventilation products for markets throughout the world. Products of the segment include dry, wet and hybrid cooling systems for the power generation, refrigeration, HVAC and industrial markets, as well as boilers, heating and ventilation products for the commercial and residential markets. This segment also provides thermal components for power generation plants and engineered services to maintain, refurbish, upgrade and modernize power stations. The segment continues to focus on expanding its global reach, including increasing its dry cooling, heating and ventilation presence in Asia, as well as its thermal components and service offerings. The segment’s South African subsidiary has a Black Economic Empowerment noncontrolling interest shareholder, which holds a 25.1% interest.

Industrial Products and Services

Our Industrial Products and Services segment comprises businesses that design, manufacture and market power systems, industrial tools and hydraulic units, precision machine components for the aerospace industry, crystal growing machines for the solar power generation market, television, radio and cell phone and data transmission broadcast antenna systems, communications and signal monitoring systems, and precision controlled industrial ovens and chambers. This segment continues to focus on global expansion opportunities.

Corporate Expense

Corporate expense generally relates to the cost of our Charlotte, NC corporate headquarters and our Asia Pacific center in Shanghai, China.

Financial data for our business segments, including the results of acquisitions from the respective dates of acquisition, were as follows:

	Three months ended
	April 2,			April 3,
	2011			2010
Revenues (1):
Flow Technology	$	455.9		$	354.0
Test and Measurement	248.9			204.4
Thermal Equipment and Services	325.3			352.4
Industrial Products and Services	168.9			173.8
Total revenues	$	1,199.0		$	1,084.6

Segment income:
Flow Technology	$	56.4		$	41.3
Test and Measurement	19.6			13.4
Thermal Equipment and Services	21.3			31.7
Industrial Products and Services	17.2			20.1
Total segment income	114.5			106.5

Corporate expense	(31.1		)	(22.7		)
Pension and postretirement expense	(9.2		)	(13.2		)
Stock-based compensation expense	(19.7		)	(11.9		)
Special charges, net	(3.1		)	(6.8		)

Consolidated operating income	$	51.4		$	51.9

(1) Under the percentage of completion method, we recognized revenues of $287.6 and $302.2 in the first quarter of 2011 and 2010, respectively. Costs and estimated earnings in excess of billings on contracts accounted for under the percentage of completion method were $237.5 and $228.1 as of April 2, 2011 and December 31, 2010, respectively. The April 2, 2011 balance includes $235.7 reported as a component of “Accounts receivable, net” and $1.8 as a component of “Other assets” in the condensed consolidated balance sheet. The December 31, 2010 balance includes $226.3 reported as a component of “Accounts receivable, net” and $1.8 as a component of “Other assets” in the condensed consolidated balance sheet. Billings in excess of costs and estimated earnings on uncompleted contracts accounted for under the percentage of completion method were $337.5 and $373.9 as of April 2, 2011 and December 31, 2010, respectively. The April 2, 2011 balance includes $330.0 reported as a component of “Accrued expenses” and $7.5 as a component of “Other long-term liabilities” in the condensed consolidated balance sheet. The December 31, 2010 balance includes $364.5 reported as a component of “Accrued expenses” and $9.4 as a component of “Other long-term liabilities” in the condensed consolidated balance sheet.

SPECIAL CHARGES

3 Months Ended

Apr. 02, 2011

SPECIAL CHARGES

SPECIAL CHARGES

(5) SPECIAL CHARGES

Special charges, net, for the three months ended April 2, 2011 and April 3, 2010 are summarized and described in more detail below:

	Three months ended
	April 2,		April 3,
	2011		2010
Flow Technology	$	1.6	$	2.7
Test and Measurement	0.7		2.8
Thermal Equipment and Services	0.8		1.2
Industrial Products and Services	—		—
Corporate	—		0.1
Total	$	3.1	$	6.8

Flow Technology segment — Charges for the three months ended April 2, 2011 related primarily to costs associated with the integration of Anhydro and Gerstenberg and with restructuring activities initiated in 2010. The charges for the three months ended April 3, 2010 related primarily to additional costs associated with restructuring activities initiated in 2009 and an impairment charge of $1.0 associated with an idle facility in Lake Mills, WI.

Test and Measurement segment — Charges for the three months ended April 2, 2011 and April 3, 2010 related primarily to costs associated with headcount reductions and consolidation activities for a number of domestic and foreign facilities.

Thermal Equipment and Services segment — Charges for the three months ended April 2, 2011 related primarily to lease exit costs associated with two facilities in Germany. The charges for the three months ended April 3, 2010 related primarily to costs associated with headcount reductions at a facility in Wuxi, China and asset impairment charges of $1.0.

Corporate — Charges for the three months ended April 3, 2010 related primarily to our legal entity reduction initiative.

The following is an analysis of our restructuring and integration liabilities for the three months ended April 2, 2011 and April 3, 2010:

	Three months ended
	April 2,			April 3,
	2011			2010
Beginning balance	$	20.7		$	26.0
Special charges (1)	3.1			4.8
Utilization — cash	(9.5		)	(10.7		)
Currency translation adjustment and other	0.8			(0.5		)
Ending balance	$	15.1		$	19.6

(1) The three months ended April 3, 2010 excludes $2.0 of non-cash special charges that impact special charges but not the restructuring and integration related liabilities.

GOODWILL AND OTHER INTANGIBLE ASSETS

3 Months Ended

Apr. 02, 2011

GOODWILL AND OTHER INTANGIBLE ASSETS

GOODWILL AND OTHER INTANGIBLE ASSETS

(7) GOODWILL AND OTHER INTANGIBLE ASSETS

The changes in the carrying amount of goodwill, by segment, were as follows:

	December 31, 2010			Goodwill resulting from business combinations		Impairments		Foreign Currency Translation and other (1)			April 2, 2011
Flow Technology
Gross Goodwill	$	702.7		$	0.3	$	—	$	25.0		$	728.0
Accumulated Impairments	—			—		—		—			—
Goodwill	702.7			0.3		—		25.0			728.0

Test & Measurement
Gross Goodwill	434.5			18.1		—		8.2			460.8
Accumulated Impairments	(257.0		)	—		—		(5.4		)	(262.4		)
Goodwill	177.5			18.1		—		2.8			198.4

Thermal Equipment and Services
Gross Goodwill	602.6			—		—		11.0			613.6
Accumulated Impairments	(114.1		)	—		—		—			(114.1		)
Goodwill	488.5			—		—		11.0			499.5

Industrial Products and Services
Gross Goodwill	351.8			—		—		(1.5		)	350.3
Accumulated Impairments	(85.9		)	—		—		—			(85.9		)
Goodwill	265.9			—		—		(1.5		)	264.4

Total
Gross Goodwill	2,091.6			18.4		—		42.7			2,152.7
Accumulated Impairments	(457.0		)	—		—		(5.4		)	(462.4		)
Goodwill	$	1,634.6		$	18.4	$	—	$	37.3		$	1,690.3

(1) Includes adjustments resulting from recent acquisitions of ($0.1) and foreign currency translation adjustments totaling $37.4.

Other Intangibles

Identifiable intangible assets comprised the following:

	April 2, 2011							December 31, 2010
	Gross Carrying Value		Accumulated Amortization			Net Carrying Value		Gross Carrying Value		Accumulated Amortization			Net Carrying Value
Intangible assets with determinable lives:
Patents	$	19.3	$	(16.8	)	$	2.5	$	24.6	$	(21.6	)	$	3.0
Technology	120.9		(26.4		)	94.5		116.7		(23.3		)	93.4
Customer relationships	266.5		(57.3		)	209.2		239.7		(51.6		)	188.1
Other	34.8		(14.7		)	20.1		35.4		(13.5		)	21.9
	441.5		(115.2		)	326.3		416.4		(110.0		)	306.4
Trademarks with indefinite lives	422.1		—			422.1		413.1		—			413.1
Total	$	863.6	$	(115.2	)	$	748.4	$	829.5	$	(110.0	)	$	719.5

Estimated annual amortization expense related to these intangible assets is $30.7 in 2011, $29.2 in 2012, $27.6 in 2013, $26.8 in 2014 and $26.2 in 2015.

At April 2, 2011, the net carrying value of intangible assets with determinable lives consisted of $174.1 in the Flow Technology segment, $77.5 in the Test and Measurement segment, $62.6 in the Thermal Equipment and Services segment, and $12.1 in the Industrial Products and Services segment. Trademarks with indefinite lives consisted of $213.8 in the Flow Technology segment, $54.8 in the Test and Measurement segment, $138.5 in the Thermal Equipment and Services segment, and $15.0 in the Industrial Products and Services segment.

We annually test the recoverability of our goodwill and indefinite-lived intangible assets during the fourth quarter based on a measurement date as of the end of the third quarter and continually monitor impairment indicators across all our reporting units. Any significant change in market conditions and estimates or judgments used to determine expected future cash flows that indicate a reduction in carrying value may give rise to impairment in the period that the change becomes known.

- Definition

Discloses the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain or loss on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss. This element may be used as a single block of text to include the entire intangible asset disclosure including data and tables.

+ References+ Details

EMPLOYEE BENEFIT PLANS

3 Months Ended

Apr. 02, 2011

EMPLOYEE BENEFIT PLANS

EMPLOYEE BENEFIT PLANS

(9) EMPLOYEE BENEFIT PLANS

Net periodic benefit expense for our pension and postretirement plans includes the following components:

Domestic Pension Plans

	Three months ended
	April 2,			April 3,
	2011			2010
Service cost	$	2.6		$	2.4
Interest cost	14.5			15.3
Expected return on plan assets	(16.5		)	(17.1		)
Amortization of unrecognized losses	5.8			9.3
Amortization of unrecognized prior service credits	(0.2		)	(0.2		)
Total net periodic benefit expense	6.2			9.7
Less: Net periodic benefit expense of discontinued operations	—			—
Net periodic benefit expense of continuing operations	$	6.2		$	9.7

Foreign Pension Plans

	Three months ended
	April 2,			April 3,
	2011			2010
Service cost	$	0.6		$	0.6
Interest cost	3.6			3.5
Expected return on plan assets	(4.1		)	(3.6		)
Amortization of unrecognized losses	0.2			0.4
Total net periodic benefit expense	0.3			0.9
Less: Net periodic benefit expense of discontinued operations	—			—
Net periodic benefit expense of continuing operations	$	0.3		$	0.9

Postretirement Plans

	Three months ended
	April 2,			April 3,
	2011			2010
Service cost	$	0.1		$	0.1
Interest cost	1.8			2.0
Amortization of unrecognized losses	1.2			0.9
Amortization of unrecognized prior service credits	(0.4		)	(0.4		)
Net periodic postretirement benefit expense of continuing operations	$	2.7		$	2.6

During the first three months of 2011, we made contributions of approximately $6.7 to our foreign and qualified domestic pension plans, of which $0.6 related to businesses classified as discontinued operations.

An increase in the number of inactive participants in one of our domestic pension plans resulted in almost all of the plan participants being inactive. Accordingly, in 2011 we began amortizing the unrecognized gains/losses over the average remaining life expectancy of the inactive participants as opposed to the average remaining service period of the active participants. This change resulted in a reduction to pension expense of approximately $5.0 during the first quarter of 2011.

- Definition

Description containing the entire pension and other postretirement benefits disclosure as a single block of text.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 158

-Paragraph 7, 21, 22

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 132R

-Paragraph 5, 6, 7, 8

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 132R

-Paragraph 8

-Subparagraph m

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 106

-Paragraph 518

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 87

-Paragraph 264

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 132R

-Paragraph 5

-Subparagraph b

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 132R

-Paragraph 5

-Subparagraph a

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 132R

-Paragraph 5

-Subparagraph h

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 132R

-Paragraph 5

-Subparagraph q

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Staff Position (FSP)

-Number FAS106-2

-Paragraph 20, 21, 22

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 03-2

-Paragraph 8

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 30

-Paragraph 26

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Implementation Guide (Q and A)

-Number FAS88

-Paragraph 63

+ Details

INDEBTEDNESS

3 Months Ended

Apr. 02, 2011

INDEBTEDNESS

INDEBTEDNESS

(10) INDEBTEDNESS

The following summarizes our debt activity (both current and non-current) for the three months ended April 2, 2011:

	December 31, 2010		Borrowings		Repayments			Other (5)		April 2, 2011
Domestic revolving loan facility	$	—	$	95.0	$	(95.0	)	$	—	$	—
6.875% senior notes	600.0		—		—			—		600.0
7.625% senior notes	500.0		—		—			—		500.0
7.50% senior notes (1)	28.2		—		(28.2		)	—		—
6.25% senior notes (2)	21.3		—		—			—		21.3
Trade receivables financing arrangement (3)	—		72.0		(21.0		)	—		51.0
Other indebtedness (4)	48.1		0.8		(0.2		)	0.9		49.6
Total debt	1,197.6		$	167.8	$	(144.4	)	$	0.9	1,221.9
Less: short-term debt	36.3									88.2
Less: current maturities of long-term debt	50.8									22.7
Total long-term debt	$	1,110.5								$	1,111.0

(1) These notes were redeemed in full in January 2011.

(2) The notes mature on June 15, 2011 and, accordingly, the total balance has been included in “Current maturities of long-term debt” within our condensed consolidated balance sheets as of April 2, 2011 and December 31, 2010.

(3) Under this arrangement, we can borrow, on a continuous basis, up to $130.0, as available.

(4) Includes balances under a purchase card program of $36.9 and $36.1 at April 2, 2011 and December 31, 2010, respectively.

(5) “Other” includes foreign currency translation on any debt instruments denominated in currencies other than the U.S. dollar.

Credit Facilities

We have senior credit facilities with a syndicate of lenders that provide for committed senior secured financing in the aggregate amount of $1,550.0 consisting of the following:

· A domestic revolving credit facility, available for loans and letters of credit, in an aggregate principal amount up to $400.0 with a final maturity of September 2012;

· A global revolving credit facility, available for loans in Euros, British Pounds and other currencies in an aggregate principal amount up to the equivalent of $200.0 with a final maturity of September 2012; and

· A foreign credit instrument facility, available for performance letters of credit and guarantees, in an aggregate principal amount in various currencies up to the equivalent of $950.0 with a final maturity of September 2012.

Our senior credit facilities require that we maintain a Consolidated Interest Coverage Ratio (generally defined as the ratio of consolidated adjusted EBITDA for the trailing four fiscal quarters ended on such date to consolidated interest expense for such period) as of the last day of any fiscal quarter of at least 3.50 to 1.00, and a Consolidated Leverage Ratio as of the last day of any fiscal quarter of no more than 3.25 to 1.00. Our senior credit facilities also contain covenants that, among other things, restrict our ability to incur additional indebtedness, grant liens, make investments, loans, guarantees or advances, make restricted junior payments, including dividends, redemptions of capital stock and voluntary prepayments or repurchases of certain other indebtedness, engage in mergers, acquisitions or sales of assets, enter into sale and leaseback transactions or engage in certain transactions with affiliates and otherwise restrict certain corporate activities. We do not expect these covenants to restrict our liquidity, financial condition or access to capital resources in the foreseeable future. Lastly, our senior credit facilities contain customary representations, warranties, affirmative covenants and events of default.

We are permitted under our senior credit facilities to repurchase our capital stock and pay cash dividends in an unlimited amount if our gross Consolidated Leverage Ratio is less than 2.50 to 1.00. If our gross Consolidated Leverage Ratio is greater than or equal to 2.50 to 1.00, the aggregate amount of such repurchases and dividend declarations cannot exceed (A) $100.0 in any fiscal year plus (B) an additional amount for all such repurchases and dividend declarations made after September 21, 2007 equal to the sum of (i) $300.0 and (ii) a positive amount equal to 50% of cumulative consolidated net income during the period from July 1, 2007 to the end of the most recent fiscal quarter for which financial information is available preceding the date of such repurchase or dividend declaration (or, in case such consolidated net income is a deficit, minus 100% of such deficit).

The weighted-average interest rate of our outstanding borrowings under our senior credit facilities was approximately 2.15% for the three months ended April 2, 2011.

At April 2, 2011, we had $91.3 and $768.7 of outstanding letters of credit issued under our revolving credit and our foreign trade facilities of our senior credit agreement, respectively. In addition, we had $2.9 of letters of credit outstanding under separate arrangements in China and South Africa.

At April 2, 2011, we were in compliance with all covenant provisions of our senior credit facilities, and the senior credit facilities did not impose any restrictions on our ability to repurchase shares or pay dividends, other than those inherent in the credit agreement. In addition, we were in compliance with all covenant provisions of our senior notes as of April 2, 2011.

DERIVATIVE FINANCIAL INSTRUMENTS

3 Months Ended

Apr. 02, 2011

DERIVATIVE FINANCIAL INSTRUMENTS

DERIVATIVE FINANCIAL INSTRUMENTS

(11) DERIVATIVE FINANCIAL INSTRUMENTS

Interest Rate Swaps

Prior to the August 2010 repayment of our variable rate term loan, we maintained interest rate protection agreements (“Swaps”) to hedge the associated interest rate risk. These Swaps, which we designated and accounted for as cash flow hedges, effectively converted the majority of the borrowings under our variable rate term loan to a fixed rate of 4.795% plus the applicable margin. In connection with the repayment of our term loan, we terminated all our Swaps.

Currency Forward Contracts

We manufacture and sell our products in a number of countries and, as a result, are exposed to movements in foreign currency exchange rates. Our objective is to preserve the economic value of non-functional currency denominated cash flows and to minimize their impact. Our principal currency exposures relate to the Euro, Chinese Yuan, South African Rand and British Pound.

From time to time, we enter into currency protection agreements (“FX forward contracts”) to manage the exposure on contracts with forecasted transactions denominated in non-functional currencies and to manage the risk of transaction gains and losses associated with assets/liabilities denominated in currencies other than the functional currency of certain subsidiaries. In addition, some of our contracts contain currency forward embedded derivatives (“FX embedded derivatives”), as the currency of exchange is not “clearly and closely” related to the functional currency of either party to the transaction. Certain of our FX forward contracts are designated as cash flow hedges, as deemed appropriate. To the extent these derivatives are effective in offsetting the variability of the hedged cash flows, changes in the derivatives’ fair value are not included in current earnings, but are included in accumulated other comprehensive loss (“AOCI”). These changes in fair value will subsequently be reclassified into earnings as a component of revenues or cost of products sold, as applicable, when the forecasted transaction impacts earnings. In addition, if the forecasted transaction is no longer probable the cumulative change in the derivatives’ fair value will be recorded as a component of other income (expense), net in the period it occurs. To the extent that a previously designated hedging transaction is no longer an effective hedge, any ineffectiveness measured in the hedging relationship is recorded in earnings in the period it occurs. We had FX forward contracts with an aggregate notional amount of $193.7 and $199.5 outstanding as of April 2, 2011 and December 31, 2010, respectively. We had FX embedded derivatives with an aggregate notional amount outstanding of $185.2 and $200.9 at April 2, 2011 and December 31, 2010, respectively. The unrealized loss, net of taxes, recorded in AOCI related to FX embedded derivatives and FX forward contracts was $4.1 as of April 2, 2011 and December 31, 2010. We anticipate reclassifying approximately $1.0 of the unrealized loss to income over the next 12 months.

Commodity Contracts

From time to time, we enter into commodity contracts to manage the exposure on forecasted purchases of commodity raw materials (“commodity contracts”). At April 2, 2011 and December 31, 2010, the outstanding notional amount of commodity contracts was 1.6 million and 1.8 million pounds of copper, respectively. We designate and account for these contracts as cash flow hedges and, to the extent these commodity contracts are effective in offsetting the variability of the forecasted purchases, the change in fair value is included in AOCI. We reclassify the AOCI associated with our commodity contracts to cost of products sold when the forecasted transaction impacts earnings. As of April 2, 2011 and December 31, 2010, the fair values of these contracts were $0.3 and $1.0, respectively, recorded as a current asset. The unrealized gain, net of taxes, recorded in AOCI was $0.4 and $0.8 as of April 2, 2011 and December 31, 2010, respectively. We anticipate reclassifying the unrealized gain to income over the next 12 months.

The following summarizes the fair value of our derivative financial instruments:

	April 2, 2011				December 31, 2010
	Balance Sheet Classification	Fair Value			Balance Sheet Classification	Fair Value
Derivative contracts designated as hedging instruments:
Commodity contracts	Other current assets	$	0.3		Other current assets	$	1.0
FX forward contracts	Other current assets	0.1			—	—
		$	0.4			$	1.0

FX forward contracts	Accrued expenses	$	(2.0	)	Accrued expenses	$	(2.9	)
		$	(2.0	)		$	(2.9	)

Derivative contracts not designated as hedging instruments:
FX forward contracts	Other current assets	$	3.4		Other current assets	$	0.5
FX embedded derivatives	Other current assets	1.2			Other current assets	2.6
		$	4.6			$	3.1

FX forward contracts	Accrued expenses	$	(0.7	)	Accrued expenses	$	(1.4	)
FX embedded derivatives	Accrued expenses	(4.7		)	Accrued expenses	(1.8		)
FX embedded derivatives	Other long-term liabilities	(26.5		)	Other long-term liabilities	(33.2		)
		$	(31.9	)		$	(36.4	)

The following summarizes the effect of derivative financial instruments in cash flow hedging relationships on AOCI and the condensed consolidated statements of operations for the three months ended April 2, 2011 and April 3, 2010:

	Amount of gain (loss) recognized in AOCI, pre-tax (1)						Classification of gain (loss)	Amount of gain (loss) reclassified from AOCI to income, pre-tax (1)
	2011			2010			reclassified from AOCI	2011			2010
Swaps	$	—		$	(4.2	)	Interest expense	$	—		$	(5.6	)
FX forward contracts	(0.5		)	(2.1		)	Cost of products sold	(0.6		)	—
FX embedded derivatives	—			1.8			Cost of products sold	—			0.2
Commodity contracts	(0.2		)	0.2			Cost of products sold	0.4			0.3
	$	(0.7	)	$	(4.3	)		$	(0.2	)	$	(5.1	)

(1) During the three months ended April 2, 2011 and April 3, 2010, losses of $0.1 and gains of $0.1, respectively, were recognized in other income (expense), net relating to derivative ineffectiveness and amounts excluded from effectiveness testing.

The following summarizes the effect of derivative financial instruments not designated as cash flow hedging relationships on the condensed consolidated statements of operations for the three months ended April 2, 2011 and April 3, 2010:

	Classification of gain (loss) recognized in	Amount of gain (loss) recognized in income
	income	2011		2010
FX forward contracts	Other income (expense), net	$	0.7	$	(0.3	)
FX embedded derivatives (1)	Other income (expense), net	1.2		(12.1		)
		$	1.9	$	(12.4	)

(1) Includes $4.6 of losses reclassified from AOCI during the three months ended April 3, 2010, resulting from the discontinuance of cash flow hedge accounting, as the forecasted transactions were determined to no longer be probable.

EQUITY AND STOCK-BASED COMPENSATION

3 Months Ended

Apr. 02, 2011

EQUITY AND STOCK-BASED COMPENSATION

EQUITY AND STOCK-BASED COMPENSATION

(12) EQUITY AND STOCK-BASED COMPENSATION

Earnings Per Share

The following table sets forth the number of weighted-average shares outstanding used in the computation of basic and diluted income per share:

	Three months ended
	April 2,	April 3,
	2011	2010
Weighted-average shares outstanding used in basic income per share	50.264	49.530
Dilutive securities — employee stock options, restricted stock and restricted stock units	0.676	0.391
Weighted-average number of common and dilutive securities used for calculating diluted income per share	50.940	49.921

The total number of stock options that were not included in the computation of diluted income per share because their exercise price was greater than the average market price of common shares was 0.112 and 0.443 for the three months ended April 2, 2011 and April 3, 2010, respectively. For the three months ended April 2, 2011, no unvested restricted stock units were excluded from the computation of diluted income per share, compared to 0.104 for the three months ended April 3, 2010, because required market thresholds for vesting (as discussed below) were not met.

Stock-based Compensation

Under the 2002 Stock Compensation Plan, as amended in 2006, the successor plan to the 1992 Stock Compensation Plan, up to 20.0 shares of our common stock may be granted to key employees and 4.548 of these shares were available for grant at April 2, 2011. The 2002 Stock Compensation Plan permits the issuance of new shares or shares from treasury upon the exercise of options, vesting of restricted stock units or granting of restricted stock.

During the three months ended April 2, 2011 and April 3, 2010, we classified excess tax benefits from stock-based compensation of $6.2 and $2.6, respectively, as financing cash flows and included such amounts in “Minimum withholdings paid on behalf of employees for net share settlements, net of proceeds from exercise of employee stock options and other” within our condensed consolidated statements of cash flows.

Restricted stock or restricted stock units may be granted to certain eligible employees or non-employee directors in accordance with applicable equity compensation plan documents and agreements. Subject to participants’ continued employment and other plan terms and conditions, the restrictions lapse and awards generally vest over three years. Market (“company performance”) thresholds have been instituted for vesting of substantially all restricted stock and restricted stock unit awards. This vesting is based on SPX shareholder return versus the S&P 500 composite index. On each vesting date, we compare the SPX shareholder return to the performance of the S&P 500 composite index for the prior year and for the cumulative period since the date of the grant. If SPX outperforms the S&P 500 composite index for the prior year, the one-third portion of the grant associated with that year will vest. If SPX outperforms the S&P composite index for the cumulative period, any unvested portion of the grant that was subject to vesting on or prior to the vesting date will vest. Restricted stock and restricted stock units that do not vest within the three-year vesting period are forfeited.

We grant restricted stock to non-employee directors under the 2006 Non-Employee Directors’ Stock Incentive Plan (the “Directors’ Plan”). Under the Directors’ Plan, up to 0.100 shares of our common stock may be granted to non-employee directors and 0.027 of these shares were available for grant at April 2, 2011. Restricted stock grants have a three-year vesting period based on SPX shareholder return versus the S&P 500 composite index, which are subject to the same company performance thresholds for employee awards described in the preceding paragraph. Restricted stock that does not vest within the three-year vesting period in accordance with these performance requirements is forfeited.

Stock options may be granted to key employees in the form of incentive stock options or nonqualified stock options, generally vest ratably over three years, which vesting may be subject to performance criteria, and expire no later than 10 years from the date of grant. The option price per share may be no less than the fair market value of our common stock at the close of business day prior to the date of grant. Upon exercise, the employee has the option to surrender previously owned shares at current value in payment of the exercise price and/or for withholding tax obligations, and, subject to certain restrictions, may receive a reload option having an exercise price equal to the current market value for the number of shares so surrendered. The reload option expires at the same time that the exercised option would have expired. Any future issuances of options under the plan will not have a reload feature, pursuant to the terms of the plan. We have not granted options to any of our employees since 2004.

The recognition of compensation expense for share-based awards, including stock options, is based on their grant date fair values. The fair value of each award is amortized over the lesser of the award’s requisite or derived service period, which is generally up to three years. Compensation expense related to restricted stock and restricted stock units totaled $19.7 and $11.9 for the three months ended April 2, 2011 and April 3, 2010, respectively.

We use the Monte Carlo simulation model valuation technique to determine fair value of our restricted stock and restricted stock units as they contain a “market condition.” The Monte Carlo simulation model utilizes multiple input variables that determine the probability of satisfying the market condition stipulated in the award and calculates the fair value of each restricted stock and restricted stock unit award. We used the following assumptions in determining the fair value of the awards granted on March 1, 2011 and March 1, 2010:

	Annual expected stock price volatility		Annual expected dividend yield		Risk-free interest rate		Correlation between total shareholder return for SPX and S&P 500 Composite Index
March 1, 2011:
SPX Corporation	61.0	%	1.27	%	1.03	%	0.7559
S&P 500 Composite Index	30.3	%	n/a		1.03	%
March 1, 2010:
SPX Corporation	62.0	%	1.64	%	1.20	%	0.7250
S&P 500 Composite Index	30.8	%	n/a		1.20	%

Annual expected stock price volatility is based on the three-year historical volatility. The annual expected dividend yield is based on annual expected dividend payments and the stock price on the date of grant. The average risk-free interest rate is based on the one-year through three-year daily treasury yield curve rate as of the grant date.

The following table summarizes the restricted stock and restricted stock unit activity from December 31, 2010 through April 2, 2011:

	Unvested Restricted Stock and Restricted Stock Units		Weighted-Average Grant-Date Fair Value
Outstanding at December 31, 2010	1.516		$	50.97
Granted	0.790		62.84
Vested	(0.633	)	51.46
Forfeited	(0.197	)	72.93
Outstanding at April 2, 2011	1.476		54.19

As of April 2, 2011, there was $43.1 of unrecognized compensation cost related to restricted stock and restricted stock unit compensation arrangements. We expect this cost to be recognized over a weighted-average period of 1.7 years.

The following table shows stock option activity from December 31, 2010 through April 2, 2011:

	Shares		Weighted- Average Exercise Price
Options outstanding at December 31, 2010	0.635		$	63.82
Exercised	(0.107	)	64.51
Forfeited	(0.003	)	48.44
Options outstanding and exercisable at April 2, 2011	0.525		63.77

The weighted-average remaining term, in years, of stock options outstanding and exercisable at April 2, 2011 was 1.0. The total number of in-the-money options exercisable on April 2, 2011 was 0.413. Aggregate intrinsic value (market value of stock less the option exercise price) represents the total pre-tax intrinsic value, based on our closing stock price on April 2, 2011, which would have been received by the option holders had all in-the-money option holders exercised their options as of that date. The aggregate intrinsic value of the options outstanding and exercisable at April 2, 2011 was $9.7. The aggregate intrinsic value of options exercised during the first three months of 2011 was $1.8, while the related amount for the first three months of 2010 was $0.4.

Accumulated Other Comprehensive Loss

The components of the balance sheet caption “Accumulated other comprehensive loss” were as follows:

	April 2, 2011			December 31, 2010
Foreign currency translation adjustment	$	312.7		$	223.2
Net unrealized losses on qualifying cash flow hedges, net of tax benefit of $2.3 and $2.2, respectively	(3.7		)	(3.3		)
Net unrealized gains on available-for-sale securities	3.7			6.1
Pension liability adjustment, net of tax benefit of $264.6 and $266.6, respectively (1)	(416.2		)	(418.6		)
Accumulated other comprehensive loss	$	(103.5	)	$	(192.6	)

(1) As of April 2, 2011 and December 31, 2010, includes $3.1 and $3.2, respectively, related to our share of the pension liability adjustment for EGS.

Common Stock in Treasury

During the three months ended April 2, 2011, “Common Stock in Treasury” was decreased by the settlement of restricted stock units issued from treasury stock of $12.7 and increased by $7.0 for common stock that was surrendered by recipients of restricted stock as a means of funding the related minimum income tax withholding requirements.

During the three months ended April 3, 2010, “Common Stock in Treasury” was decreased by the settlement of restricted stock units issued from treasury stock of $12.0 and increased by $5.1 for common stock that was surrendered by recipients of restricted stock as a means of funding the related minimum income tax withholding requirements.

Dividends

The dividends declared during the first quarters of 2011 and 2010 were $0.25 per share and totaled $12.7 and $12.5, respectively. First quarter dividends were paid on April 5, 2011 and April 6, 2010.

Changes in Equity

A summary of the changes in equity for the three months ended April 2, 2011 and April 3, 2010 is provided below:

	April 2, 2011									April 3, 2010
	SPX Corporation Shareholders’ Equity			Noncontrolling Interest			Total Equity			SPX Corporation Shareholders’ Equity			Noncontrolling Interest			Total Equity

Equity, beginning of period	$	2,097.7		$	6.3		$	2,104.0		$	1,870.8		$	10.7		$	1,881.5
Net income (loss)	23.1			1.7			24.8			22.1			(0.8		)	21.3
Net unrealized gains (losses) on qualifying cash flow hedges, net of tax benefit (provision) of $0.1 and ($1.8), respectively	(0.4		)	—			(0.4		)	3.6			—			3.6
Net unrealized loss on available-for-sale securities	(2.4		)	—			(2.4		)	—			—			—
Pension liability adjustment, net of tax benefit (provision) of ($2.0) and $5.4, respectively	2.4			—			2.4			16.7			—			16.7
Foreign currency translation adjustments	89.5			0.4			89.9			(61.2		)	0.2			(61.0		)
Total comprehensive income (loss)	112.2			2.1			114.3			(18.8		)	(0.6		)	(19.4		)
Dividends declared	(12.7		)	—			(12.7		)	(12.5		)	—			(12.5		)
Exercise of stock options and other incentive plan activity, including tax benefit of $5.6 and $1.6, respectively	17.2			—			17.2			7.1			—			7.1
Amortization of restricted stock and stock unit grants	19.7			—			19.7			11.9			—			11.9
Restricted stock and restricted stock unit vesting, net of tax withholdings	(16.6		)	—			(16.6		)	(11.8		)	—			(11.8		)
Dividends attributable to noncontrolling interest	—			(4.1		)	(4.1		)	—			—			—
Other changes in noncontrolling interest	—			1.1			1.1			—			0.2			0.2
Equity, end of period	$	2,217.5		$	5.4		$	2,222.9		$	1,846.7		$	10.3		$	1,857.0

CONTINGENCIES AND OTHER MATTERS

3 Months Ended

Apr. 02, 2011

CONTINGENCIES AND OTHER MATTERS

CONTINGENCIES AND OTHER MATTERS

(13) CONTINGENCIES AND OTHER MATTERS

General

Numerous claims, complaints and proceedings arising in the ordinary course of business, including those relating to litigation matters (e.g., class actions, derivative lawsuits and contracts, intellectual property and competitive claims), environmental matters, and risk management matters (e.g., product and general liability, automobile, and workers’ compensation claims), have been filed or are pending against us and certain of our subsidiaries. Additionally, we may become subject to significant claims, of which we are currently unaware, or the claims of which we are aware may result in us incurring a significantly greater liability than we anticipate. This may also be true in connection with past or future acquisitions. While we maintain property, cargo, auto, product, general liability, environmental, and directors’ and officers’ liability insurance and have acquired rights under similar policies in connection with acquisitions that we believe cover a portion of these claims, this insurance may be insufficient or unavailable (e.g., because of insurer insolvency) to protect us against potential loss exposures. In addition, we have increased our self-insurance limits over the past several years. While we believe we are entitled to indemnification from third parties for some of these claims, these rights may be insufficient or unavailable to protect us against potential loss exposures. However, we believe that our accruals related to these items are sufficient and that these items and our rights to available insurance and indemnity will be resolved without material adverse effect, individually or in the aggregate, on our financial position, results of operations and cash flows. These accruals totaled $431.9 (including $367.3 for risk management matters) and $436.2 (including $366.1 for risk management matters) at April 2, 2011 and December 31, 2010, respectively. Of these amounts, $362.0 and $368.0 were included in “Other long-term liabilities” within our condensed consolidated balance sheets at April 2, 2011 and December 31, 2010, respectively, with the remainder included in “Accrued expenses.”

We had insurance recovery assets related to risk management matters of $319.9 and $320.0 at April 2, 2011 and December 31, 2010, respectively, included in “Other assets” within our condensed consolidated balance sheets.

Litigation Matters

We are subject to litigation matters that arise in the normal course of business. In our opinion, these matters are either without merit or of a kind that should not have a material adverse effect individually or in the aggregate on our financial position, results of operations or cash flows. However, we cannot assure that these proceedings or claims will not have a material adverse effect on our financial position, results of operations or cash flows.

Environmental Matters

Our operations and properties are subject to federal, state, local and foreign regulatory requirements relating to environmental protection. It is our policy to comply fully with all applicable requirements. As part of our effort to comply, we have a comprehensive environmental compliance program that includes environmental audits conducted by internal and external independent professionals, as well as regular communications with our operating units regarding environmental compliance requirements and anticipated regulations. Based on current information, we believe that our operations are in substantial compliance with applicable environmental laws and regulations, and we are not aware of any violations that could have a material adverse effect on our business, financial condition, results of operations or cash flows. We have liabilities for site investigation and/or remediation at 93 sites that we own or control. In addition, while we believe that we maintain adequate accruals to cover the costs of site investigation and/or remediation, we cannot provide assurance that new matters, developments, laws and regulations, or stricter interpretations of existing laws and regulations will not materially affect our business or operations in the future.

Our environmental accruals cover anticipated costs, including investigation, remediation, and operation and maintenance of clean-up sites. Our estimates are based primarily on investigations and remediation plans established by independent consultants, regulatory agencies and potentially responsible third parties. Accordingly, our estimates may change based on future developments, including new or changes in existing environmental laws or policies, differences in costs required to complete anticipated actions from estimates provided, future findings of investigation or remediation actions, or alteration to the expected remediation plans. It is our policy to realize a change in estimate once it becomes probable and can be reasonably estimated. We do not discount our environmental accruals and do not reduce them by anticipated insurance recoveries. We do take into account third-party indemnification from financially viable parties in determining our accruals where there is no dispute regarding the right to indemnification.

In the case of contamination at offsite, third-party disposal sites, we have been notified that we are potentially responsible and have received other notices of potential liability pursuant to various environmental laws at 27 sites at which the liability has not been settled, and only 10 of which have been active in the past few years. These laws may impose liability on certain persons that are considered jointly and severally liable for the costs of investigation and remediation of hazardous substances present at these sites, regardless of fault or legality of the original disposal. These persons include the present or former owners or operators of the site and companies that generated, disposed of or arranged for the disposal of hazardous substances at the site. We are considered a “de minimis” potentially responsible party at most of the sites, and we estimate that the aggregate probable remaining liability at these sites is immaterial.

We conduct extensive environmental due diligence with respect to potential acquisitions, including environmental site assessments and such further testing as we may deem warranted. If an environmental matter is identified, we estimate the cost and either establish a liability, purchase insurance or obtain an indemnity from a financially sound seller. However, in connection with our acquisitions or dispositions, we may assume or retain significant environmental liabilities, some of which we may be unaware. The potential costs related to these environmental matters and the possible impact on future operations are uncertain due in part to the complexity of government laws and regulations and their interpretations, the varying costs and effectiveness of various clean-up technologies, the uncertain level of insurance or other types of recovery, and the questionable level of our responsibility. We record a liability when it is both probable and the amount can be reasonably estimated. Due to the uncertainties previously described, we are unable to reasonably estimate the amount of possible additional losses associated with the resolution of these matters beyond what has been recorded.

In our opinion, after considering accruals established for such purposes, remedial actions for compliance with the present laws and regulations governing the protection of the environment are not expected to have a material adverse impact on our business, financial condition, results of operations or cash flows.

Risk Management Matters

We are self-insured for certain of our workers’ compensation, automobile, product and general liability, disability and health costs, and we believe that we maintain adequate accruals to cover our retained liability. Our accruals for risk management matters are determined by us, are based on claims filed and estimates of claims incurred but not yet reported, and generally are not discounted. We consider a number of factors, including third-party actuarial valuations, when making these determinations. We maintain third-party stop-loss insurance policies to cover certain liability costs in excess of predetermined retained amounts. This insurance may be insufficient or unavailable (e.g., because of insurer insolvency) to protect us against loss exposure.

Collaborative Arrangements

Collaborative arrangements are defined as a contractual arrangement in which the parties are (1) active participants to the arrangements and (2) exposed to significant risks and rewards that depend on the commercial success of the endeavor. Costs incurred and revenues generated from transactions with third parties are required to be reported by the collaborators on the appropriate line item in their respective income statements. Refer to our disclosure on consortium arrangements below.

We enter into consortium arrangements for certain projects within our Thermal Equipment and Services segment. Under such arrangements, each consortium member is responsible for performing certain discrete items of work within the total scope of the contracted work and the consortium expires when all contractual obligations are completed. The revenues for these discrete items of work are defined in the contract with the project owner and each consortium member bearing the profitability risk associated with its own work. Our consortium arrangements typically provide that each consortium member assumes its responsible share of any damages or losses associated with the project; however, the use of a consortium arrangement typically results in joint and several liability for the consortium members. If responsibility cannot be determined or a consortium member defaults, then the consortium members are responsible according to their share of the contract value. Within our consolidated financial statements, we account for our share of the revenues and profits under the consortium arrangements. As of April 2, 2011, our share of the aggregate contract value on open consortium arrangements was $412.3 (of which approximately 48.4% had been recognized as revenue), and the aggregate contract value on open consortium arrangements was $1,022.2. As of December 31, 2010, our share of the aggregate contract value on open consortium arrangements was $381.4 (of which approximately 45.1% had been recognized as revenue), and the aggregate contract value on open consortium arrangements was $948.7. At April 2, 2011 and December 31, 2010, we recorded liabilities of $3.4 and $3.2, respectively, representing the estimated fair value of our potential obligation under the joint and several liability provisions associated with the consortium arrangements.

U.S. Health Care Reform Legislation

In the first quarter of 2010, the Patient Protection and Affordable Care Act of 2010 (the “PPAC Act”) was enacted. As discussed in Note 14, the PPAC Act eliminated a portion of the federal income tax deduction available to companies that provide prescription drug benefits to retirees under Medicare Part D. We currently are evaluating other prospective effects of the PPAC Act and the related effects on our business.

INCOME TAXES

3 Months Ended

Apr. 02, 2011

INCOME TAXES

INCOME TAXES

(14) INCOME TAXES

Unrecognized Tax Benefits

As of April 2, 2011, we had gross unrecognized tax benefits of $98.0 (net unrecognized tax benefits of $79.5), of which $77.5, if recognized, would impact our effective tax rate from continuing operations.

We classify interest and penalties related to unrecognized tax benefits as a component of our income tax provision. As of April 2, 2011, gross accrued interest excluded from the amounts above totaled $16.1 (net accrued interest of $11.8). There were no significant penalties recorded during the three months ended April 2, 2011 or April 3, 2010.

Based on the outcome of certain examinations or as a result of the expiration of statute of limitations for certain jurisdictions, we believe that within the next 12 months it is reasonably possible that our previously unrecognized tax benefits could decrease by approximately $30.0 to $35.0. The previously unrecognized tax benefits relate to a variety of tax issues including the ability to claim certain foreign tax credits, deductibility of interest expense in certain jurisdictions, and tax matters relating to prior acquisitions or dispositions.

Uncertain Tax Positions

We perform reviews of our income tax positions on a continuous basis and accrue for potential uncertain positions when we determine that an uncertain position meets the criteria of the Income Taxes Topic of the Codification. Accruals for these uncertain tax positions are recorded in “Income taxes payable” and “Deferred and other income taxes” in the accompanying condensed consolidated balance sheets based on the expectation as to the timing of when the matters will be resolved. As events change and resolution occurs, these accruals are adjusted, such as in the case of audit settlements with taxing authorities.

The effective income tax rate for the three months ended April 3, 2010 was impacted unfavorably by a domestic charge of $6.2 associated with the taxation of prescription drug costs for retirees under Medicare Part D as a result of the first quarter 2010 enactment of the PPAC Act. This charge was offset partially by net discrete tax benefits of $5.4 associated with the resolution of certain domestic and foreign tax positions.

The IRS currently is performing an audit of our 2008 and 2009 federal income tax returns. At this stage, the outcome of the audit is uncertain; however, we believe that any contingencies are adequately provided for. We do not expect to conclude this examination within the next twelve months.

During 2010, the IRS completed the field examination of our 2006 and 2007 federal income tax returns and issued a Revenue Agent’s report. We disagreed with and have protested certain adjustments to the Appeals Office of the IRS. While the resolution of these adjustments may result in tax liabilities that may differ from the accruals established, we believe that the resolution of these matters will not have a material adverse effect on our financial position, results of operations or cash flows. It is reasonably possible that these matters will be resolved within the next twelve months.

State income tax returns generally are subject to examination for a period of three to five years after filing the respective tax returns. The impact on such tax returns of any federal changes remains subject to examination by various states for a period of up to one year after formal notification to the states. We have various state income tax returns in the process of examination, administrative appeals or litigation. We believe that any uncertain tax positions related to these examinations have been adequately provided for.

We have various foreign income tax returns under examination. Significant jurisdictions with tax examinations underway include: Canada for the 2000 to 2006 tax returns, Germany for the 2002 to 2009 tax returns, and United Kingdom for the 2008 tax return. We believe that any uncertain tax positions related to these examinations have been adequately provided for.

An unfavorable resolution on one or more of the above matters could have a material adverse effect on our results of operations or cash flows in the quarter and year in which an adjustment is recorded or the tax is due or paid. As audits and examinations are still in process or we have not yet reached the final stages of the appeals process for the above matters, the timing of the ultimate resolution and any payments that may be required for the above matters cannot be determined at this time.

Upon the conclusion of our disposition activities discussed in Note 3 to these condensed consolidated financial statements, we may recognize an additional income tax provision or benefit, generally as part of discontinued operations.

FAIR VALUE

3 Months Ended

Apr. 02, 2011

FAIR VALUE

FAIR VALUE

(15) FAIR VALUE

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In the absence of active markets for the identical assets or liabilities, such measurements involve developing assumptions based on market observable data and, in the absence of such data, internal information that is consistent with what market participants would use in a hypothetical transaction that occurs at the measurement date. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions. Preference is given to observable inputs. These two types of inputs create the following fair value hierarchy:

· Level 1 — Quoted prices for identical instruments in active markets.

· Level 2 — Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.

· Level 3 — Significant inputs to the valuation model are unobservable.

The following section describes the valuation methodologies we use to measure different financial instruments at fair value on a recurring basis.

Derivative Financial Instruments

Our financial derivative assets and liabilities include FX forward contracts, FX embedded derivatives and commodity contracts, which are valued using valuation models that measure fair value using observable market inputs such as forward rates, interest rates, our own credit risk and our counterparties’ credit risks. Based on these inputs, the derivative assets and liabilities are classified within Level 2 of the valuation hierarchy. We have not made any adjustments to the inputs obtained from the independent sources. Based on our continued ability to enter into forward contracts, we consider the markets for our fair value instruments to be active. We primarily use the income approach, which uses valuation techniques to convert future amounts to a single present amount.

As of April 2, 2011, there has been no significant impact to the fair value of our derivative liabilities due to our own credit risk as the related instruments are collateralized under our senior credit facilities. Similarly, there has been no significant impact to the fair value of our derivative assets based on our evaluation of our counterparties’ credit risk.

Investments in Equity Securities

Our available-for-sale securities include equity investments that are traded in active international markets. They are measured at fair value using closing stock prices from active markets and are classified within Level 1 of the valuation hierarchy.

Certain of our investments in equity securities that are not readily marketable are accounted for under the fair value option, with such values determined by multidimensional pricing models. These models consider market activity based on modeling of securities with similar credit quality, duration, yield and structure. A variety of inputs are used, including benchmark yields, reported trades, non-binding broker/dealer quotes, issuer spread and reference data including market research publications. Market indicators, industry and economic events are also considered. We have not made any adjustments to the inputs obtained from the independent sources. At April 2, 2011 and December 31, 2010, these assets had a fair value of $8.2 and $8.5, respectively, which were estimated using various valuation models, including the Monte-Carlo simulation model.

Assets and liabilities measured at fair value on a recurring basis include the following as of April 2, 2011:

	Fair Value Measurements Using
	Level 1		Level 2		Level 3
Current assets — FX embedded derivatives, FX forward contracts and commodity contracts	$	—	$	5.0	$	—
Noncurrent assets — Investment in equity securities and available-for-sale securities	10.4		—		8.2
Current liabilities — FX forward contracts and FX embedded derivatives	—		7.4		—
Long-term liabilities — FX embedded derivatives	—		26.5		—

Assets and liabilities measured at fair value on a recurring basis include the following as of December 31, 2010:

	Fair Value Measurements Using
	Level 1		Level 2		Level 3
Current assets — FX embedded derivatives, FX forward contracts and commodity contracts	$	—	$	4.1	$	—
Noncurrent assets — Investment in equity securities and available-for-sale securities	12.8		—		8.5
Current liabilities — FX forward contracts and FX embedded derivatives	—		6.1		—
Long-term liabilities — FX embedded derivatives	—		33.2		—

The table below presents a reconciliation of our investment in equity securities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the three months ended April 2, 2011, including net unrealized losses included in earnings.

	Three months ended April 2, 2011
Balance at beginning of year	$	8.5
Purchases	—
Losses included in earnings	(0.3		)
Balance at end of year	$	8.2

During the three months ended April 3, 2010, we recorded impairment charges of $2.0 to “Special charges, net” related to idle facilities and certain machinery and equipment (See Note 5). The fair values of these assets totaled $2.9 at April 3, 2010 and were based on the estimated selling prices. We determined the estimated selling prices by obtaining information in the specific markets being evaluated, including comparable sales of similar assets and assumptions about demand in the market for these assets (unobservable inputs - Level 3).

The carrying amount of cash and equivalents and receivables reported in our condensed consolidated balance sheets approximates fair value because of the short maturity of those instruments.

The fair value of our debt instruments, based on borrowing rates available to us at April 2, 2011 for similar debt, was $1,315.5 at April 2, 2011, compared to our carrying value of $1,221.9.

- Definition

This item represents the complete disclosure regarding the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments, assets, and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the Company is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risk is are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References+ Details

Document and Entity Information	3 Months Ended
Document and Entity Information	Apr. 02, 2011	May 02, 2011
Document and Entity Information
Entity Registrant Name	SPX CORP
Entity Central Index Key	0000088205
Document Type	10-Q
Document Period End Date	Apr. 02, 2011
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		50,999,507
Document Fiscal Year Focus	2011
Document Fiscal Period Focus	Q1

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Apr. 02, 2011	Apr. 03, 2010
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
Discontinued operations, net cash proceeds from dispositions		$ 6.7
Dividends paid, noncontrolling interest distributions	$ 2.9

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)	Apr. 02, 2011	Dec. 31, 2010
CONDENSED CONSOLIDATED BALANCE SHEETS
Common stock, issued	98,614,016	98,068,416
Common stock, outstanding	50,985,674	50,294,261
Common stock in treasury, shares	47,628,342	47,774,155